Shilpa Medicare Ltd. (SHILPAMED) 52 Week High Streak: Consecutive High Analysis

Shilpa Medicare Ltd. 52 Week High Streak has now held for the second straight session, with the stock trading within 2% of its 52-week high and logging a 4.57% cumulative move across the streak. The latest peak stood at Rs 1,075 and the share price last traded at Rs 1,070. The latest Univest figures confirm the repeated near-high pattern, but they do not establish a company-specific catalyst for the continued move.

Shilpa Medicare Ltd. (SHILPAMED) last traded at Rs 1,070 versus the previous close of Rs 1,056.6, after opening at Rs 1,049.75 and touching the same level as the day low before moving to Rs 1,075. The company carries a market capitalisation of Rs 20,011.93 crore. For readers, a repeated near-high pattern is different from a single-day move because it shows that the stock has remained near its yearly high across sessions rather than briefly touching it once.

Shilpa Medicare Ltd. 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 1,070
Previous Close	Rs 1,056.6
Today's Move	+Rs 13.4 (+1.27%)
Open	Rs 1,049.75
High	Rs 1,075
Low	Rs 1,049.75
Market Capitalisation	Rs 20,011.93 crore

Shilpa Medicare Ltd. (SHILPAMED) traded at Rs 1,070 versus the previous close of Rs 1,056.6, a rise of 1.27%. The stock opened at Rs 1,049.75, reached a high of Rs 1,075 and touched a low of Rs 1,049.75.

Shilpa Medicare Ltd. share price today remained firm in early trade, with the stock last trading at Rs 1,070, up Rs 13.4 or 1.27% from the previous close of Rs 1,056.6. The session opened at Rs 1,049.75, matched the day low at the same level and moved up to Rs 1,075, which also marks the current 52-week high used in this streak analysis. The price was trading near the upper end of the day’s range at the time of observation.

The move matters because it came while the stock was already in a repeated near-high phase. Shilpa Medicare Ltd. 52 Week High Streak is therefore being shaped by a sustained price position rather than by one isolated print. The market capitalisation stood at Rs 20,011.93 crore, placing the company among larger listed names in its sector. For readers tracking Shilpa Medicare Ltd. share price today, the important part is not only the daily change but the fact that the stock has stayed close to its yearly peak for another session.

What the Repeated 52-Week Highs Show

Shilpa Medicare Ltd. 52 Week High Streak points to a stock that has remained close to its one-year peak across consecutive sessions. The key factual takeaway is simple: the stock has not just reached the upper end of its range once, but has stayed there for a second straight session. That makes Shilpa Medicare Ltd. part of the broader set of 52 Week High Stocks and keeps it visible in Stocks At One Year High Today searches.

The streak also creates a useful comparison point for readers looking at Shilpa Medicare Ltd. Stock Performance over a short span. The cumulative rise across the streak is 4.57%, which is the figure that separates this article from a single-session update. The current 52-week high is the reference point for the move. The latest data confirms the pattern, but it does not identify a fresh company-specific trigger that explains why the stock has continued to trade near that level.

For investors, Shilpa Medicare Ltd. New One Year High headlines can be less informative than the repeated pattern itself. A second straight session near the yearly high suggests persistence in price action, while still leaving the reason for the move open. That is why Shilpa Medicare Ltd. Back To Back 52 Week Highs deserve a separate read from the first breakout story.

Shilpa Medicare Ltd. (SHILPAMED) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 20,011.93 crore
P/E Ratio	69.51x
P/B Ratio	7.69x
ROE	9.82%
ROCE	11.43%
EPS	Rs 15.2
Book Value Per Share	Rs 137.34
Dividend Yield	0.06%

Shilpa Medicare Ltd. (SHILPAMED) fundamental metrics show P/E 69.51x, P/B 7.69x, ROE 9.82%, ROCE 11.43%. These figures provide context only and are not a buy or sell signal.

Shilpa Medicare Ltd. has a market capitalisation of Rs 20011.93 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 69.51x, P/B at 7.69x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.82% and ROCE of 11.43%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.2, book value per share of Rs 137.34, dividend yield of 0.06%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.2x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	69.51x
Benchmark Median P/E	28.2x
Benchmark Average P/E	41.87x
Benchmark P/E Range	0x to 699.02x
Company P/B Ratio	7.69x
Benchmark Median P/B	2.87x
Company ROE	9.82%
Benchmark Median ROE	11.74%
Company ROCE	11.43%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 20,011.93 crore
Benchmark Median Market Cap	Rs 773.14 crore

Shilpa Medicare Ltd. (SHILPAMED) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 69.51x, which is above the benchmark median of 28.2x, a difference of +146.49%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Shilpa Medicare Ltd. (SHILPAMED) has a ROE of 9.82%, which is below the benchmark median of 11.74%, a difference of -16.35%. Shilpa Medicare Ltd. (SHILPAMED) has a ROCE of 11.43%, which is below the benchmark median of 13.63%, a difference of -16.14%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Caplin Point Laboratories Ltd.	CAPLIPOINT	21,683.86	31.34	5.68	20.79	24.97
Pfizer Ltd.	PFIZER	18,151.33	24.36	4.06	17.16	23.39
ONESOURCE SPECL PHARMA L	ONESOURCE	17,963.65	0	3.11	-1.26	0.44
Suven Pharmaceuticals Ltd.	COHANCE	17,366.09	164.5	4.54	4.02	6.12
Granules India Ltd.	GRANULES	23,163.1	35.74	4.83	14.13	15.74

Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 69.51x compared with the displayed peer median of 31.34x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.82% compares with a peer median of 14.13% across the companies shown in the table. ROCE stood at 11.43% versus the displayed peer median of 15.74%, providing a capital-efficiency comparison. Shilpa Medicare Ltd. (SHILPAMED) has a market capitalisation of Rs 20,011.93 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Shilpa Medicare Ltd.

• Shilpa Medicare Ltd. 52 Week High Streak has now lasted for the second straight session, keeping the stock near its one-year peak.
• The cumulative move across the streak is 4.57%, which gives a fuller read than a one-session price update.
• The stock last traded at Rs 1,070, only a little below the current 52-week high.
• Valuation remains rich, with a P/E of 69.51 and a P/B of 7.69 versus lower industry medians.
• The company remains a key name in Healthcare and Pharmaceuticals & Drugs, where peers are trading on a wide valuation range.

About Shilpa Medicare Ltd.

Shilpa Medicare Ltd. is a listed company in the Healthcare sector and the Pharmaceuticals & Drugs industry. The stock trades on NSE and BSE under the symbol SHILPAMED and has a market capitalisation of Rs 20,011.93 crore. The latest metrics show revenue-related and return-related measures being watched closely by investors alongside its market pricing.

For readers following Shilpa Medicare Ltd. share price today, the company remains important because it sits in a sector where valuation and earnings quality are both closely tracked. Shilpa Medicare Ltd. Fundamental Analysis, peer positioning and repeated near-high trading are all part of the same market conversation for this stock.

Why this matters for investors: Shilpa Medicare Ltd. 52 Week High Streak can stay on watchlists when the stock continues trading near its yearly peak, even if the latest move has not yet established a fresh company-specific catalyst.

Frequently Asked Questions

What does Shilpa Medicare Ltd. 52 Week High Streak mean?

Ans. It means the stock has traded within 2% of its 52-week high for consecutive sessions. In this case, Shilpa Medicare Ltd. 52 Week High Streak has extended to a second straight session, showing repeated trading near the yearly peak.

How many sessions has Shilpa Medicare Ltd. stayed near its 52-week high?

Ans. According to the latest Univest data, Shilpa Medicare Ltd. has stayed within 2% of its 52-week high for two consecutive sessions. The current streak label is the second straight session.

What is the cumulative move across the Shilpa Medicare Ltd. 52 Week High Streak?

Ans. The cumulative streak move is 4.57%. That figure captures the full repeated-high phase better than a single-day price change and is the key differentiator in this article.

Has the data confirmed a company-specific catalyst for the move?

Ans. No. The latest figures confirm the price pattern, but they do not identify a company-specific catalyst. Readers should treat the repeated near-high trading as a market pattern, not as proof of a single trigger.

How does Shilpa Medicare Ltd. compare with its healthcare peers on valuation?

Ans. Shilpa Medicare Ltd. trades at a higher P/E and P/B than many peers in the healthcare and pharmaceuticals group. Its valuation is above the industry median, which places it in the richer part of the peer range.

What do the return ratios show for Shilpa Medicare Ltd.?

Ans. ROE is 9.82% and ROCE is 11.43%. Both are below the latest industry medians, which suggests the stock’s valuation is not being supported by above-median return ratios right now.

Why are investors watching Shilpa Medicare Ltd. today?

Ans. Investors are watching because the stock has stayed near its yearly peak for a second straight session, the cumulative move is notable, and the valuation stands at a premium relative to much of the sector.

What should readers monitor next in Shilpa Medicare Ltd. Stock News?

Ans. Readers should watch whether the stock continues to trade near the 52-week high, whether the valuation premium persists, and whether new company information appears that can explain the repeated near-high pattern.

Track Shilpa Medicare Ltd. (SHILPAMED) Share Price on Univest

Use Shilpa Medicare Ltd. (SHILPAMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.